[HTML][HTML] High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity
…, G Barbás, L Lopez, P Carreño, G Castro, E Raboy… - Nature …, 2023 - nature.com
The range of vaccines developed against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2)
provides a unique opportunity to study immunization across different platforms…
provides a unique opportunity to study immunization across different platforms…
Distinct immune signatures discriminate SARS-CoV-2 vaccine combinations
…, G Barbás, L Lopez, P Carreño, G Castro, E Raboy… - medRxiv, 2022 - medrxiv.org
Several vaccines have been found effective against COVID-19, usually administered in
homologous regimens, with the same vaccine used for the prime and boost doses. However, …
homologous regimens, with the same vaccine used for the prime and boost doses. However, …
[HTML][HTML] Estudio de base poblacional de seroprevalencia y factores asociados a la infección por SARS-CoV-2 en Córdoba, Argentina
…, G Franchini, P Carreño, E Raboy… - Cadernos de Saúde …, 2022 - SciELO Public Health
Los estudios seroepidemiológicos permiten conocer la distribución indirecta de las
enfermedades, detectando marcadores séricos de inmunidad y demostrando infecciones no …
enfermedades, detectando marcadores séricos de inmunidad y demostrando infecciones no …
A population-based study on seroprevalence and factors associated with SARS-CoV-2 infection in Córdoba, Argentina
…, G Franchini, P Carreño, E Raboy… - Cadernos de Saúde …, 2022 - SciELO Brasil
Los estudios seroepidemiológicos permiten conocer la distribución indirecta de las
enfermedades, detectando marcadores séricos de inmunidad y demostrando infecciones no …
enfermedades, detectando marcadores séricos de inmunidad y demostrando infecciones no …
Distinct immune signatures discriminate SARS-CoV-2 vaccine combinations (preprint)
…, G Barbas, L Lopez, P Carreno, G Castro, E Raboy… - 2022 - pesquisa.bvsalud.org
Several vaccines have been found effective against COVID-19, usually administered in
homologous regimens, with the same vaccine used for the prime and boost doses. However, …
homologous regimens, with the same vaccine used for the prime and boost doses. However, …
[PDF][PDF] Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273
CA Pascuale, A Varese, DS Ojeda, ME Pasinovich… - Cell Reports …, 2022 - cell.com
Heterologous vaccination against coronavirus disease 2019 (COVID-19) provides a rational
strategy to rapidly increase vaccination coverage in many regions of the world. Although …
strategy to rapidly increase vaccination coverage in many regions of the world. Although …
[HTML][HTML] A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1.
RG Kulka, B Raboy, R Schuster, HA Parag… - Journal of Biological …, 1988 - Elsevier
The effect of restrictive temperature on ubiquitin conjugation activity has been studied in
cells of ts20, a temperature-sensitive cell cycle mutant of the Chinese hamster cell line E36. …
cells of ts20, a temperature-sensitive cell cycle mutant of the Chinese hamster cell line E36. …
RAD6 gene product of Saccharomyces cerevisiae requires a putative ubiquitin protein ligase (E3) for the ubiquitination of certain proteins
G Sharon, B Raboy, HA Parag, D Dimitrovsky… - Journal of Biological …, 1991 - Elsevier
The RAD6 (UBC2) gene of Saccharomyces cerevisiae which is involved in DNA repair, induced
mutagenesis, and sporulation, encodes a ubiquitin-conjugating enzyme (E2). Since the …
mutagenesis, and sporulation, encodes a ubiquitin-conjugating enzyme (E2). Since the …
What else does your biometric data reveal? A survey on soft biometrics
Recent research has explored the possibility of extracting ancillary information from primary
biometric traits viz., face, fingerprints, hand geometry, and iris. This ancillary information …
biometric traits viz., face, fingerprints, hand geometry, and iris. This ancillary information …
[HTML][HTML] The ubiquitin-activating enzyme, E1, is required for stress-induced lysosomal degradation of cellular proteins
R Gropper, RA Brandt, S Elias, CF Bearer… - Journal of Biological …, 1991 - Elsevier
ts85, a cell line that harbors a mutant thermolabile ubiquitin-activating enzyme, E1, fails to
degrade short lived proteins at the restrictive temperature (Ciechanover, A., Finley, D., and …
degrade short lived proteins at the restrictive temperature (Ciechanover, A., Finley, D., and …
